Adaptive Biotechnologies Corporation
ADPT
$24.66
$0.321.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.33% | 64.97% | 62.69% | 59.30% | 43.21% |
| Total Depreciation and Amortization | -11.71% | -9.77% | -7.39% | -10.47% | -14.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 28.19% | -12.11% | -14.45% | -40.62% | -41.70% |
| Change in Net Operating Assets | -34.91% | -105.74% | -230.97% | -117.59% | -6.02% |
| Cash from Operations | 73.89% | 68.32% | 51.70% | 44.80% | 37.75% |
| Capital Expenditure | -29.38% | 26.85% | 19.24% | 50.78% | 68.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.98% | -61.43% | -49.78% | 10.92% | -32.61% |
| Cash from Investing | -144.92% | -63.44% | -51.22% | 16.03% | -29.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 401.16% | 474.58% | 12,515.35% | 4,313.93% | 3,960.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,293.88% | 474.58% | 12,515.35% | 4,313.93% | 3,960.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 849.06% | 229.24% | 230.20% | 132.95% | 65.73% |